news roundup
PAREXEL, a provider of global biopharmaceutical services, has launched a new China Advisory Service to help global biopharmaceutical companies participate in China. Services include agency engagement and agreements, early development, clinical operations, and more.
|
|
|
|
| Advertisement
Outcomes in Focus: Best Practices for eCOA
This eBook covers considerations and practical advice for smooth eCOA implementation; secrets to eCOA success from industry insiders; and new opportunities for the use of eCOA in clinical trials.
 Download Your Free eBook |
CRF Health, a provider of patient-centered eSource technology solutions, announced the awarding of two new contracts by top-20 pharma companies, which will see the company's eCOA solutions used to capture patient reported outcomes in 15 global dermatology trials including a range of Phase II-IV studies.
| Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
North America: Tuesday, November 13, 2018 at 11am EDT | 10am CDT | 8am PDT
 Register Now |
A new report on EU's digital health strategy also calls for closer coordination of national HTA arrangements—but both policy initiatives couldn't be more different.
FDA is joining with other federal health agencies and the biomedical community to advance science, regulatory policies, and reimbursement strategies to combat the need for new medicines for infectious diseases.
|
|
|
| Advertisement
The Potential for Disease-Modifying Therapies in Parkinson's Disease
Tuesday, November 13, 2018 at 11am EST|8am PST|4pm GMT|5pm CEST
 Register Now |
| Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand
 Learn More |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
Although it is unlikely that mock demonstrators will be seen at any drug information or regulatory conferences, pharmacovigilance software is indeed having its "Salesforce" moment.
| Advertisement
Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
On Demand
 Learn More |
To inform our understanding of public and patient trust and confidence, this article provides a high-level summary of the results of two studies monitoring trends in international public and patient attitudes and perceptions.
|
|
Blog Posts
Key tips and resources to help evade the common traps of market landscaping—today an increasingly high-stakes and comprehensive task during clinical development.
| Advertisement
IDENTIFYING NASH PATIENTS: Solutions and Strategies
On Demand
 Learn More |
At PanAgora's Clinical Trials Patient Experience Summit, three main topics stood out; companies engrained patient centricity guiding principles in their operational models, the new concept of patient connectivity is emerging, and digital health is rapidly gaining ground in clinical trials.
|
|
Oncology
Q&A highlights one such example of M&A movement in the CRO space toward mid-sized companies focused in specific disease indications.
|
|
In this interview, Lisa Dilworth, as VP, Rare and Orphan Diseases at Synteract, will discuss common challenges with rare disease studies, how to encounter them, and how the rare disease space is evolving.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
